Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today ...

BioMed X and Servier launch first research team in France to pioneer AI-driven antibody engineering: Heidelberg, Germany Saturday, April 18, 2026, 15:00 Hrs [IST] BioMed X, a lead ...

Every thought, memory, and feeling we experience depends on trillions of tiny connection points in the brain called synapses.

Professional packaging box production transcends simple printing. It is a multidisciplinary process that seamlessly ...

A few years ago, it was supposed to be on its last legs as tenants downsized and moved out. Now it’s going to be home to the ...

Recipients recognized for excellence in classroom instruction, innovative teaching methods and distinction in research ...

Discover how thoughtful design can revolutionize AI systems. Learn more about the future of AI at MLDS 2026. Read now!

A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

Today's leading programs recognize that young children possess a remarkable capacity for absorbing complex concepts when ...